Standard BioTools Inc. (LAB)
$0.65-2.99%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-07-31
- Market cap
- $254M
- Avg volume
- 3.1M
- Beta
- 1.40
- P/E (TTM)
- -2.82
- Short % float
- 6.30%
- Days to cover
- 1.3
- SI change
- +21.7%
- 1W
- -4.41%
- 1M
- -21.69%
- 3M
- -36.89%
- YTD
- -48.82%
- vs SPY 1W
- -3.22%
- vs SPY 1M
- -25.01%
- vs SPY 3M
- -39.28%
- vs SPY YTD
- -60.57%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- MIRASELLMIRA Pharmaceuticals, Inc.CRISISQ -10$0.79+3.95%
- PLYXSELLPolaryx Therapeutics, Inc. Common StockQ -31$1.87-9.66%
- TELOSELLTelomir Pharmaceuticals, Inc. Common StockRECOVERYQ -12$1.17+3.54%
- ELABSELLPMGC Holdings Inc.CRISISQ -30$6.52-2.10%
- WGSBUYGeneDx Holdings Corp.RECOVERYQ -2$85.19-2.15%
- BYSISELLBeyondSpring Inc.CRISISQ -2$0.71-1.39%
- RLYBBUYRallybio CorporationBULLQ -2$16.80-0.18%
- SMTIBUYSanara MedTech Inc.BULLQ 7$34.38-0.20%
- UPCSELLUniverse Pharmaceuticals Inc.CRISISQ -21$5.36+1.13%
- KROSBUYKeros Therapeutics, Inc.RECOVERYQ -7$10.78-2.27%
- DHAISELLDIH Holding US, Inc.CRISISQ -21$0.00
- BNGOBUYBionano Genomics, Inc.RECOVERYQ -8$1.22+1.67%
Industry peers
FMP comparable companies · ranked by market cap
- CGEMBUYCullinan Therapeutics, Inc.$1.3BBULLQ 6$21.82+0.65%
- AVNSSELLAvanos Medical, Inc.$1.2BBULLQ 10$24.99+0.04%
- BVSBUYBioventus Inc.$950MBULLQ 1$14.02-2.50%
- CBLLBUYCeriBell, Inc.$908MBULLQ -2$23.94-1.07%
- VREXBUYVarex Imaging Corporation$780MBULLQ -5$18.52+0.05%
- KIDSBUYOrthoPediatrics Corp.$644MBULLQ 11$25.07-2.26%
- CTKBBUYCytek Biosciences, Inc.$573MRECOVERYQ -10$4.44-7.69%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 9
- VALUE
- 7
- GROWTH
- 32
- GARP
- 4
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-10.9%
REV YoY-
ROE-18.2%
EPS YoY-
ROA-13.9%
GROSS49
OP-95
NET-103
[VALUATION]
P/E TTM-2.82
P/E FWD-
SECTOR PE22.66
INDUSTRY PE12.01
P/B0.47
P/FCF-
EV/EBITDA-0.14
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.20
ALTMAN Z-
CURR RATIO9.10
ND/EBITDA-
BETA1.40
